Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study [Phase 1, Phase 2]
Phase 1/2 clinical trial of ABT-335 (choline fenofibrate) for dyslipidemia has completed with results posted in 2011. The study evaluated re…
-
CLINICAL_TRIALS withdrawal · 2011-04-12Clinical Trial Update: Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes
AstraZeneca-sponsored clinical trial on dyslipidemia treatment in Thailand investigating cardiovascular outcomes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study [Phase 1]
A Phase 1 pilot study evaluating the effects of etravirine on endothelial function and related metabolic markers in HIV-uninfected adults, w…
-
CLINICAL_TRIALS withdrawal · 2010-12-10Clinical Trial Update: Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors [Phase 3]
A Phase 3 trial evaluating the impact of rimonabant on regression of asymptomatic cardiovascular damage was terminated.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia [Phase 3]
A Phase 3 trial of rimonabant in abdominally obese patients with dyslipidemia has been terminated. The update notes the study status but doe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )
This entry reports a completed clinical trial evaluating rosuvastatin-based therapy (RosUvaStatin) for Korean patients with dyslipidemia and…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT) [Phase 3]
Phase 3 clinical trial update evaluating the HDL-C-raising mechanism of rosuvastatin (Crestor) by measuring steps of reverse cholesterol tra…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
An observational study on adherence to statin therapy in patients with high cholesterol (dyslipidemia) completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome [NA]
A completed clinical trial evaluating the impact of low- and moderate-fat diets on lipids, inflammation, and vascular reactivity in individu…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia [NA]
This clinical trial update reports the metabolic effects of an 8-week Niaspan (extended-release niacin) treatment in adults with abdominal o…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. [Phase 3]
Phase 3 trial evaluating the efficacy of a pioglitazone/metformin combination in adults with type 2 diabetes mellitus and dyslipidemia; resu…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004) [Phase 2]
Phase 2 study of MK1903 in patients with dyslipidemia completed; results have been posted.
-
FDA approval · 2010-09-14FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC. Fenofibric acid is a lipid-lowe…
-
FDA approval · 2010-09-13FDA Approved: GEMFIBROZIL — Original Application (Northstar RxLLC)
FDA approved the original ANDA for gemfibrozil from Northstar RxLLC, providing a generic version of the lipid-lowering drug.
-
CLINICAL_TRIALS trial_result · 2010-09-10Clinical Trial Update: Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
AstraZeneca-sponsored study in Bulgaria that investigated undertreatment of patients with dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED) [Phase 4]
Phase 4 trial evaluating Vytorin (ezetimibe/simvastatin) for newly diagnosed dyslipidemia has completed with results posted in August 2010.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: The Acute Effects of Oleic Acid Enriched-diets on Lipids, Insulin Sensitivity and Serum Inflammatory Markers [NA]
A completed clinical trial evaluating the acute effects of oleic acid-enriched diets on lipid profiles, insulin sensitivity, and inflammator…
-
FDA approval · 2010-04-30FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the approved product under …
-
CLINICAL_TRIALS research · 2010-04-29Clinical Trial Update: Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients [NA]
A completed clinical trial update focused on improving adherence to cholesterol-lowering prescribing guidelines for hospitalized patients wi…
-
FDA label_change · 2010-04-22FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO [Phase 3]
Phase 3 trial evaluating a fenofibrate/metformin fixed-dose combination versus metformin alone in patients with dyslipidemia and glucose met…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)
A completed clinical trial evaluating the efficacy of rosuvastatin (Crestor) in Korean patients with dyslipidemia and diabetes.
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension [Phase 3]
Phase 3 trial comparing COREG MR to TOPROL-XL on lipid profiles in normolipidemic or mildly dyslipidemic patients with hypertension. The stu…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients [Phase 3]
A Phase 3 study compared pitavastatin and pravastatin in elderly patients with hypercholesterolemia or combined dyslipidemia; results were p…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors [Phase 3]
A Phase 3 trial comparing pitavastatin to simvastatin in adults with hypercholesterolemia or dyslipidemia and risk factors for coronary hear…